The present pilot study is designed to assess the extent to which BOTOX and MYOBLOC cause
muscle atrophy in spastic patients. The primary objective is to assess whether there is
statistically significant difference in muscle atrophy between the two groups over a one year
period.
Phase:
Phase 4
Details
Lead Sponsor:
Georgetown University
Collaborator:
Solstice Neurosciences
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA rimabotulinumtoxinB